AI assistant
Sending…
INSMED Inc — Director's Dealing 2024
Aug 14, 2024
30150_dirs_2024-08-14_a4396e63-5c01-416a-adff-704c74833738.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-08-12
Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-12 | Common Stock | S | 9469 | $72.49 | Disposed | 100100 | Direct |
Footnotes
F1: This is the weighted average sales price representing 9,469 shares sold at prices ranging from $72.36 to $72.63 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F2: Includes 809 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
More from INSMED Inc
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19